0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Screening for Biological Response Modifiers: Methods and Rationale (Paperback, Softcover reprint of the original 1st ed. 1985) Loot Price: R2,765
Discovery Miles 27 650
Screening for Biological Response Modifiers: Methods and Rationale (Paperback, Softcover reprint of the original 1st ed. 1985):...

Screening for Biological Response Modifiers: Methods and Rationale (Paperback, Softcover reprint of the original 1st ed. 1985)

James E. Talmadge, Isaiah J. Fidler, R. K. Oldham

Series: Developments in Oncology, 29

 (sign in to rate)
Loot Price R2,765 Discovery Miles 27 650 | Repayment Terms: R259 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Developments in Oncology, 29
Release date: November 2011
First published: 1985
Authors: James E. Talmadge • Isaiah J. Fidler • R. K. Oldham
Dimensions: 235 x 155 x 11mm (L x W x T)
Format: Paperback
Pages: 194
Edition: Softcover reprint of the original 1st ed. 1985
ISBN-13: 978-1-4612-9624-9
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4612-9624-2
Barcode: 9781461296249

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Kanker Schmanker!
Madelein Rust Paperback R320 R275 Discovery Miles 2 750
Cancer: A Love Story - Memoir Of A…
Lauren Segal Paperback  (1)
R353 Discovery Miles 3 530
A Summary of: Cancer as a Metabolic…
Dr. Thomas Seyfried Paperback R447 Discovery Miles 4 470
How to Starve Cancer - ...and Then Kill…
Jane McLelland Paperback R593 Discovery Miles 5 930
The Cancer Diet Cookbook - Comforting…
Dionne Detraz Paperback R420 R328 Discovery Miles 3 280
Never Ever Give Up - The Inspiring Story…
Erik Rees Paperback R487 R407 Discovery Miles 4 070
Famous Old People - Being the Second…
Nathaniel Hawthorne Paperback R383 Discovery Miles 3 830
Knowledge Beats Cancer
Albert Stegmann Alberts, Stegman Alberts, Alberts Paperback R320 R295 Discovery Miles 2 950
Kennis Klop Kanker
Albert Stegmann Alberts, Stegman Alberts, Alberts Paperback R320 R295 Discovery Miles 2 950
Coping Successfully with Prostate Cancer
Tom Smith Paperback R239 R226 Discovery Miles 2 260
My Best Worst Year - A Breast Cancer…
Alison Tucker Paperback R280 R224 Discovery Miles 2 240
Cancer
Susan E Pories, Marsha A Moses, … Hardcover R1,611 Discovery Miles 16 110

See more

Partners